NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
October 24, 2023 08:00 ET
|
NexImmune, Inc.
A JDRF funded grant is being used to explore the combination of NexImmune’s antigen specific nanoparticles and an anti-CD3 mAb for prevention and treatment of type 1 diabetes GAITHERSBURG, Md.,...
Blood Glucose Monitoring System Market revenue to hit USD 46 Billion by 2033, says Research Nester
July 13, 2023 07:30 ET
|
Research Nester
New York, July 13, 2023 (GLOBE NEWSWIRE) -- The global blood glucose monitoring system market size is expected to expand at ~10% CAGR from 2023 to 2033. The market is anticipated to garner a revenue...
Artificial Pancreas Device System (APDS) Market Worth $3.58Bn, Globally, by 2028 at 20.28% CAGR | The Insight Partners
April 05, 2023 05:52 ET
|
The Insight Partners
Pune, INDIA., April 05, 2023 (GLOBE NEWSWIRE) -- According to our new research study on “Artificial Pancreas Device System Market Forecast to 2028 – by Type and Geography,” the market is expected to...
Type 1 Diabetes Market Size is Estimated to Reach US$ 13.64 Bn by 2030, With a Growing CAGR of 7.6% Over the Forecast Period 2023-2030 | Research by SNS Insider
February 24, 2023 09:00 ET
|
SNS Insider pvt ltd
New York, Feb. 24, 2023 (GLOBE NEWSWIRE) -- “The Type 1 Diabetes Market Size was valued at US$ 7.59 billion in 2022, and is projected to reach US$ 13.64 billion by 2030, with a growing CAGR of 7.6%...
Diabeloop and EOFlow Partner to Offer a Wearable AID With a Smartphone App
January 11, 2023 23:31 ET
|
Diabeloop SA
PARIS, Jan. 11, 2023 (GLOBE NEWSWIRE) -- EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery systems, and Diabeloop, a leader in diabetes automated...
Beta Bionics Appoints Dr. Steven Russell as Chief Medical Officer in Preparation for the Commercial Launch of the iLet Bionic Pancreas System
January 04, 2023 12:00 ET
|
Beta Bionics, Inc.
CONCORD, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. — a clinical-stage medical technology company — announced the appointment of Steven Russell, MD, Ph.D., to the role of Chief...
Beta Bionics Appoints Sean Saint as CEO and Board Member
August 15, 2022 16:00 ET
|
Beta Bionics, Inc.
Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational devices limited by Federal (or United States) law to investigational use. Not available for sale. CONCORD, Mass., Aug. 15, 2022 ...
Type 1 Diabetes Pipeline Landscape Analysis of 80+ Companies by DelveInsight
August 08, 2022 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Type 1 Diabetes Pipeline Landscape Analysis of 80+ Companies by DelveInsight Type 1 Diabetes pipeline involves 80+ key companies continuously...
Increasing Diabetic Patient Pool to Push Sales of Insulin Storage Devices across Geographies: Fact.MR Study
August 01, 2022 19:30 ET
|
FACT.MR
Seoul, South Korea, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Sales of insulin storage devices across the world are predicted to increase at a CAGR of 8.1% across the forecast period (2022-2027). In 2022,...
vTv Therapeutics Announces Investment by CinRx Pharma
July 25, 2022 07:00 ET
|
vTv Therapeutics Inc.
HIGH POINT, N.C., July 25, 2022 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced entry into agreements that include a $10 million investment by CinPax, LLC (“CinPax”), a...